Provided by Tiger Trade Technology Pte. Ltd.

Jazz Pharmaceuticals PLC

249.56
+5.022.05%
Volume:229.48K
Turnover:56.63M
Market Cap:16.20B
PE:17.06
High:251.26
Open:244.78
Low:241.39
Close:244.54
52wk High:266.38
52wk Low:123.88
Shares:64.91M
Float Shares:62.69M
Volume Ratio:0.65
T/O Rate:0.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.63
EPS(LYR):-5.8403
ROE:22.11%
ROA:6.86%
PB:3.37
PE(LYR):-42.73

Loading ...

Jazz Pharmaceuticals initiated with a Buy at Canaccord

TIPRANKS
·
Jul 17

Gain Therapeutics Names Joanne Taylor Chief Scientific Officer, Promotes Terenzio Ignoni to COO

Reuters
·
Jul 16

Jazz Pharmaceuticals is Maintained at Overweight by Barclays

Dow Jones
·
Jul 14

Jazz Pharmaceuticals Plc : Barclays Raises Target Price to $260 from $253

THOMSON REUTERS
·
Jul 14

Jazz Pharmaceuticals (JAZZ) Receives a Buy from Jefferies

TIPRANKS
·
Jul 13

Biopharma Pricing Power Seen as Key Swing Factor for Q2 Earnings, BofA Says

MT Newswires Live
·
Jul 11

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 10

Jazz Pharmaceuticals Plc : Deutsche Bank Raises Target Price to $270 from $250

THOMSON REUTERS
·
Jul 09

Jazz Pharmaceuticals price target lowered to $254 from $256 at Truist

TIPRANKS
·
Jul 07

Jazz Pharmaceuticals is Maintained at Buy by Truist Securities

Dow Jones
·
Jul 07

Jazz Pharma Director Bruce C. Cozadd Disposes of 6,000 Shares for $1.44 Million

Reuters
·
Jul 07

Jazz Pharmaceuticals Investors Eye Ziihera Launch in GEA as Key Driver, UBS Says

MT Newswires Live
·
Jul 02

Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), BeOne Medicines (ONC) and Zevra Therapeutics (ZVRA)

TIPRANKS
·
Jul 01

Jazz Pharma director Mark Douglas Smith disposes of 1,157 shares worth $266,146.35

Reuters
·
Jun 18

Jazz Pharma, AbCellera ink antibody deal worth up to $876 million

Reuters
·
Jun 17

Jazz Pharmaceuticals, AbCellera Ink $876 Million Cancer Treatment Pact

Dow Jones
·
Jun 17

Jazz Pharmaceuticals, AbCellera collaborate for TCE multispecific antibodies

TIPRANKS
·
Jun 17

Jazz Pharmaceuticals, AbCellera team up on T-cell engaging multispecific antibodies for GI cancers

Reuters
·
Jun 17

Jazz Pharmaceuticals and Abcellera Announce Collaboration to Discover Next-Generation T-Cell Engaging Multispecific Antibodies

THOMSON REUTERS
·
Jun 17

Abcellera Biologics - Collaboration Includes $56 Mln Upfront and up to $792 Mln Option Fees per Program

THOMSON REUTERS
·
Jun 17